Reaction

Product Used For Unknown Indication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,231 reports · 36 co-occurring drugs

As of the last recalculation, Product Used For Unknown Indication appears in 1,231 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 135.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Miconazole Nitrate	66	135.0	136.1
Meperidine Hydrochloride	49	93.6	94.1
Rizatriptan Benzoate	50	86.6	87.0
Botulinum Toxin Type A	41	57.7	57.9
Esomeprazole Magnesium Capsule, Delayed Release	41	49.4	49.5
Esomeprazole Magnesium Delayed Release Capsules	41	49.4	49.5
Esomeprazole Magnesium Dihydrate	41	49.2	49.3
Oxycodone And Acetaminophen	47	35.4	35.5
Acetaminophen And Codeine	19	26.8	26.8
Diclofenac Potassium, Film Coated	12	24.3	24.4
Diclofenac Potassium Tablets	12	24.3	24.4
Acetaminophen, Aspirin, And Caffeine	28	23.0	23.0
Diclofenac Potassium	14	22.1	22.2
Triamcinolone Acetonide Ointment Usp, 0.05%	28	20.7	20.7
Diclofenac Sodium 1%	37	18.0	18.0
Diclofenac Sodium Topical	37	18.0	18.0
Diclofenac Sodium Topical Gel, 1%	37	18.0	18.0
Telmisartan	18	17.3	17.3
Tramadol Hydrochloride	36	16.6	16.6
Triamcinolone Acetonide	29	16.2	16.2
Acetaminophen, Aspirin (Nsaid) And Caffeine	16	16.1	16.1
Propranolol Hydrochloride	59	14.5	14.5
Esomeprazole	49	13.9	13.9
Venlafaxine	56	13.8	13.8
Duloxetine	53	13.4	13.4
Diclofenac Sodium	92	11.1	11.1
Ibuprofen Sodium	24	9.6	9.6
Rifampin	8	9.3	9.3
Ibuprofen Tablets, Coated	23	9.3	9.3
Onabotulinumtoxina	35	7.9	7.9
Irinotecan Hydrochloride	5	6.6	6.6
Sarilumab	9	5.8	5.8
Crisaborole	3	5.3	5.3
Dupilumab	98	3.7	3.7
Adapalene	13	1.2	1.2
Salicylic Acid	3	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.